These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3720210

  • 1. Accuracy of 11 methods for predicting theophylline dose.
    Rodvold KA, Paloucek FP, Zell M.
    Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH, Burkle WS.
    Clin Pharm; 1984 May; 3(2):174-8. PubMed ID: 6723223
    [Abstract] [Full Text] [Related]

  • 3. Theophylline: constant-rate infusion predictions.
    Mesquita CA, Sahebjami H, Imhoff T, Thomas JP, Myre SA.
    Ther Drug Monit; 1984 May; 6(2):157-63. PubMed ID: 6740734
    [Abstract] [Full Text] [Related]

  • 4. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC, Gotz VP, Robinson JD, Russell WL, Ryerson GG.
    Clin Pharm; 1983 May; 2(4):347-52. PubMed ID: 6883961
    [Abstract] [Full Text] [Related]

  • 5. Nonlinear regression program to individualize oral theophylline dosage.
    Bauer LA, Black DJ, Koup JR.
    Clin Pharm; 1984 May; 3(3):288-90. PubMed ID: 6547379
    [Abstract] [Full Text] [Related]

  • 6. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH, O'Connor T, Lam G, Lui CY, Al-Bazzaz FJ, Chiou WL.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [Abstract] [Full Text] [Related]

  • 7. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A, Mirabella A, Ferrara G, Mangiacavallo A, Bonanno A, Bonsignore G.
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [Abstract] [Full Text] [Related]

  • 8. Use of a pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm.
    Pancorbo S, Davies S, Raymond JL.
    Am J Hosp Pharm; 1981 Jun; 38(6):851-6. PubMed ID: 7246557
    [Abstract] [Full Text] [Related]

  • 9. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL, Maddux MS, Organek HW, Bauman JL.
    Arch Intern Med; 1983 Apr; 143(4):794-6. PubMed ID: 6838301
    [Abstract] [Full Text] [Related]

  • 10. A comparison of absorption rate models in the prediction of steady-state plasma concentrations during oral theophylline administration.
    Paterson CM, Hudson SA, Jefferson GC.
    J Clin Pharm Ther; 1987 Feb; 12(1):39-46. PubMed ID: 3449562
    [Abstract] [Full Text] [Related]

  • 11. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M, Fukutomi O, Kondo N, Kato Z, Nakashima Y, Shinoda S, Agata H, Kondo T, Imaeda N, Orii T.
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [Abstract] [Full Text] [Related]

  • 12. Clinical utility of the single point method for theophylline maintenance dose prediction.
    Abad J, Pastor A, Prieto L, Palop J, Jiménez Torres V, Castro J.
    Allergol Immunopathol (Madr); 1987 Nov; 15(6):355-9. PubMed ID: 3445876
    [Abstract] [Full Text] [Related]

  • 13. Absorption of theophylline from conventional and sustained-release tablets.
    Fagerström PO, Mellstrand T, Svedmyr N.
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
    [Abstract] [Full Text] [Related]

  • 14. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R, Kelly HW, Howick J, McWilliams BC.
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [Abstract] [Full Text] [Related]

  • 15. Prediction of steady-state plasma theophylline concentration by Bayesian algorithm.
    Imaeda N, Takagi K, Hasegawa T, Saito H, Mizukami Y.
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):588-93. PubMed ID: 3209276
    [Abstract] [Full Text] [Related]

  • 16. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW, Zech K, Fischer R.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [Abstract] [Full Text] [Related]

  • 17. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T, Svedmyr N, Fagerström PO.
    Eur J Respir Dis Suppl; 1980 Dec; 109():54-60. PubMed ID: 6934088
    [Abstract] [Full Text] [Related]

  • 18. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML, Johnson CE, Grambau G, Weg JG.
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [Abstract] [Full Text] [Related]

  • 19. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
    Plusa T, Józefczak E, Raczka A.
    Allergol Immunopathol (Madr); 1989 Jan; 17(1):29-32. PubMed ID: 2750638
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS, Robertson C, Correia J, Isles AF, Levison H, Macleod SM.
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.